Module

Das Curriculum des englischsprachigen Programms besteht aus vier wesentlichen Abschnitten. Sämtliche Module werden unter Einbeziehung von in ethischer Hinsicht relevanter Aspekte des Lehrinhalts und mit besonderem Schwerpunkt auf Berücksichtigung der Anwendung entsprechend jeweils ethisch vertretbarer Handlungsoptionen in der praktischen Umsetzung des Erlernten unterrichtet.

Die Pflichtmodule der Basisphase (Foundation, 4 x 6 CP) schaffen eine solide Grundlage in relevanten Management- und betriebswirtschaftlichen Themenbereichen, abgestimmt auf praktischen Spezifika der Pharmaindustrie.

This module focuses on the comprehensive analysis of management control system as an essential function of management to ensure that the organization’s objectives and strategies are carried out effectively.

  • Discussion of different control mechanisms concerning the organization’s financial performance
  • Analysis of market and accounting-based result controls for performance measurement and evaluation
  • Discussion of control problems related to uncontrollable factors, ethical issues and corporate governance aspects.

The course focuses on the vital role of employees in an enterprise, organizational behavior, and importance of motivation. This course attempts to build understanding and skills in leading and managing people and organizations.

  • Employee: i.e. requirements concerning motivation, work structuring, optimal decision making
  • Teams: i.e. employee management, team management, role of social norms, peer effects
  • Organization: i.e. change, culture, compensation, performance measurement

The module focuses on fundamental questions important for understanding corporate finance. Course participants will learn basic concepts related to assessment of investments and financing of corporations. The course introduces key concepts based on modern finance theory such as

  • Interest rate
  • Risk
  • Diversification
  • Market equilibrium
  • Capital structure

This module introduces concepts related to strategic analysis and development. We will discuss different methods of strategic analysis, including such topics as:

  • Organizational goals and vision
  • Industry analysis
  • Capability and resource analysis
  • Vertical integration
  • Cost leadership
  • Internal and external growth
  • Roles and tasks of corporate headquarters
  • Implementation of corporate strategies

Die Pflichtmodule der Vertiefungsphase (Concentration, 4 x 5 CP) vertiefen ausgewählte Management-Themen im Kontext der Pharmaindustrie und geben einen Überblick über die pharmazeutische Wertschöpfungskette.

The course will provide an introduction into strategic innovation management from a theoretical perspective. Participants will learn how to successfully structure and manage innovative projects in innovative (pharma) companies. The course will cover such topics as

  • Significance of disruptive innovations
  • Innovation and technology development models
  • Financing and assessment of innovations

We will also discuss approaches to price determination of innovative pharmaceutical products, especially after the expiry of the patent.

This module focuses on successful work and management of research and development teams in pharmaceutical companies. We will cover the following topics:

  • Foundations of different leadership concepts
  • Principles and mechanisms of action of successful teams
  • Theories and concepts of team leadership
  • Communication methods and instruments
  • Neuroscientific aspects of team work
  • Motivation of research and development teams

This module consists of two parts:

1. Introduction into the fundamentals of intellectual property and patent law, exploitation of patents, in particular through licensing agreements, and internal patent management

2. Introduction into national and European pharmaceutical law, the German Drugs Act and The Social Code Book regulations relating to pharmaceuticals

The course will build the understanding of the pharmaceutical value chain, from research and development, production, quality control and assurance, regulatory affairs, pharmacovigilance to market access and reimbursement. The course also serves as an introduction to the elective modules.

The structure and the content of the Master of Pharma Business Administration are matched to meet the needs of the pharma industry and set the program apart from other education and training formats in the market.

1:/user_upload/Images/09_Master_of_Pharma_Business_Administration/Advisory_Board/oschmann.png Stefan OschmannChairman of the Executive Board & CEO, Merck

Die Wahlpflichtmodule des Spezialisierungsphase (Electives, wähle 4 x 5 CP) fokussieren sich auf hochaktuelle praxisrelevante pharmaspezifische Inhalte. Angeboten wird ein breites Spektrum an Modulen, aus denen Studierende eine Auswahl je nach persönlichem oder beruflichem Interesse treffen können.

Im Anschluss an die dreisemestrige Vorlesungsphase ist das Pflichtmodul „Scientific Methods for Research & Writing“ zu absolvieren, das den Studierenden für die Vorbereitung auf die Masterarbeit notwendige wissenschaftliche Methoden im betriebswirtschaftlichen Kontext vermittelt. Die das Studium abschließende Masterarbeit soll zeigen, dass die oder der Studierende in der Lage ist, innerhalb einer vorgegebenen Frist eine Fragestellung aus einem Fachgebiet des Pharmamanagements selbständig fundiert wissenschaftlich zu bearbeiten und Lösungsvorschläge zu formulieren. Dabei baut die Masterarbeit auf dem während des Studiums erlangten Wissen auf und verbindet dieses mit einer Fragestellung aus der Unternehmenspraxis.